Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept in Psoriasis to Identify Pigmented Lesions
NCT01053819Phase 4Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Sep 2007
- Primary completion
- Apr 2012
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of etanercept in psoriasis, sponsored by University of Alabama at Birmingham. Primary endpoint: Change From Baseline in the Number of Pigmented Lesions on Skin Previously Covered by Psoriatic Plaques at 6 months. Started Sep 2007; status: completed.
02
Drugs
etanercept
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT01053819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01053819.